文献速递神经眼科

医学文献中「视乳头水肿」一词的不当使用:跨专科病例报告的系统综述

Inappropriate Use of the Term "Papilledema" in the Medical Literature: A Systematic Review of Case Reports across Specialties.
PubMed 文献 · Ophthalmology · 2022-10-03

该横断面循证研究检索2011年1月至2022年3月Ovid MEDLINE和EMBASE中标题、摘要或关键词含「视乳头水肿」的病例报告,共纳入722篇,按类型1(无颅内压升高证据即使用该词)、类型2(检查即诊断视乳头水肿而尚无颅内压升高证据)、类型3(兼具两错)评级。共发现482处错误(66.8%),仅眼科在所有专科中错误率低,但所有纳入报告≥10篇的专科错误率均>30%。

要点

  • 722篇病例报告中共482处错误(66.8%),其中类型1错误12处、类型2错误360处、类型3错误110处,无错误240篇。
  • 眼科、神经内科和神经外科是报告最多的领域,但仅眼科在所有专科中错误率低;所有纳入≥10篇报告的专科错误率均>30%。
  • 错误率降低与更高影响因子期刊、非开放获取出版模式、官方语言为英语的来源国显著相关,与发表年份及文章引用次数无显著关联。

核心结论

  • 「视乳头水肿」一词即使在眼科病例报告中也被广泛误用,该错误传播可误导对视盘水肿患者的诊疗。
  • 作者认为,结果虽限于病例报告,但提示需要更严格的同行评审标准以及医学教育中增加神经眼科内容。

研究设计与样本

  • 横断面循证研究,方案注册于Open Science Framework(数字对象标识符:10.17605/OSF.IO/BUQS3)。
  • 从Ovid MEDLINE和EMBASE纳入2011年1月至2022年3月间标题、摘要或文章关键词含「视乳头水肿」的病例报告。
  • 按类型1(无颅内压升高证据即使用「视乳头水肿」)、类型2(检查即诊断「视乳头水肿」而尚无颅内压升高证据)、类型3(兼具类型1和2错误)或无错误进行评级。

主要发现

  • 722篇病例报告中共482处错误(66.8%),其中类型1错误12处、类型2错误360处、类型3错误110处、无错误240篇。
  • 眼科、神经内科和神经外科是报告最多的领域,但仅眼科在所有专科中错误率低。
  • 所有纳入报告≥10篇的专科错误率均>30%。
  • 错误率降低与更高影响因子期刊、非开放获取出版模式、官方语言为英语的来源国显著相关。
  • 错误率与发表年份无显著关联,文章引用次数与任何类型错误发生率的关系未达统计学显著。

关键数值与推荐

  • 「视乳头水肿」指继发于颅内压升高的视盘水肿。
  • 偏倚风险分析表明错误发生与病例报告研究设计质量无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出结果仅限于病例报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: The term "papilledema" is often misused in different ways when describing nonintracranial pressure-related optic disc edema (ODE) or on fundoscopic examination. However, the extent of these errors is unknown among case reports. CLINICAL RELEVANCE: "Papilledema" refers to ODE secondary to raised intracranial pressure (ICP). Papilledema is a leading reason for referral to neuro-ophthalmologists. In any specialty setting, papilledema must be distinguished from other causes of ODE because it implies a unique pathophysiology and management strategy. If managed inappropriately, papilledema may cause permanent vision loss. METHODS: Cross-sectional evidence-based study with protocol registered on Open Science Framework (digital object identifier: 10.17605/OSF.IO/BUQS3). From Ovid MEDLINE and EMBASE, we included case reports with "papilledema" in their title, abstract, or article keywords between January 2011 and March 2022. Studies were graded for the following errors: type 1 (using "papilledema" without evidence of elevated ICP), type 2 (declaring "papilledema" on examination before finding evidence of elevated ICP), type 3 (both errors type 1 and 2), or no error. RESULTS: Among 722 case reports, there was a total of 482 errors (66.8%). There were 12 type 1 errors, 360 type 2 errors, 110 type 3 errors, and 240 studies with no errors. Ophthalmology, neurology, and neurosurgery were the most represented fields, yet only ophthalmology had a low prevalence of errors among all specialties. Regardless, all specialties with at least 10 included reports had a high error prevalence (>30%). Reduced error prevalence was significantly associated with higher impact factor journals, non-open-access publication models, and origin countries with an English official language. Error prevalence was not significantly associated with publication year. Also, the relationship between article citation counts and the prevalence of any type of error did not reach significance. Risk of bias analysis indicated that error occurrence was unrelated to the quality of case report study design. CONCLUSION: "Papilledema" is widely misused even among ophthalmology case reports. When allowed to propagate, this error can mislead care delivery to patients with ODE. Our results, although limited to case reports, indicate a need for more thorough peer-review standards and neuro-ophthalmology exposure in medical education.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Tao B, Vosoughi A, Margolin E, et al. Inappropriate Use of the Term "Papilledema" in the Medical Literature: A Systematic Review of Case Reports across Specialties. Ophthalmology. 2022. PMID: 36195254. doi:10.1016/j.ophtha.2022.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。